Unique Biomarkers for B-cell Function Predict the Serum Response to Pandemic H1N1 Influenza Vaccine

Overview

Journal Int Immunol

Specialty Allergy & Immunology

Date 2012 Jan 28

PMID 22281510

Citations 59

Authors

Daniela Frasca

Alain Diaz

Maria Romero

Mitch Phillips

Nicholas V Mendez

Ana Marie Landin

Bonnie B Blomberg

Affiliations

Soon will be listed here.

Abstract

In order to develop predictive markers for a beneficial humoral immune response, we evaluated the in vivo and in vitro response to the pandemic (p)H1N1 vaccine in young and elderly individuals. We measured serum antibody response and associated this with the in vitro B-cell response to the vaccine, measured by activation-induced cytidine deaminase (AID). Both responses decrease with age and are significantly correlated. The percentage of switched memory B cells in blood, both before and after vaccination, is decreased with age. The percentage of switched memory B cells at t0 correlates with the hemagglutination inhibition response and therefore, we suggest that this may be used as a predictive marker for B-cell responsiveness. AID induced by CpG before vaccination also predicts the robustness of the vaccine response. Plasmablasts showed a trend to increase after vaccination in young individuals only. This report establishes molecular biomarkers of response, percentage of switched memory B cells and AID response to CpG, useful for identifying individuals at risk of poor response and also for measuring improvements in vaccines and monitoring optimal humoral responses.

Citing Articles

A spatial sequencing atlas of age-induced changes in the lung during influenza infection.

Kasmani M, Topchyan P, Brown A, Brown R, Wu X, Chen Y Nat Commun. 2023; 14(1):6597.

PMID: 37852965 PMC: 10584893. DOI: 10.1038/s41467-023-42021-y.

Obesity accelerates age defects in B cells, and weight loss improves B cell function.

Frasca D, Romero M, Diaz A, Blomberg B Immun Ageing. 2023; 20(1):35.

PMID: 37460937 PMC: 10351107. DOI: 10.1186/s12979-023-00361-9.

Inflammation and aging: signaling pathways and intervention therapies.

Li X, Li C, Zhang W, Wang Y, Qian P, Huang H Signal Transduct Target Ther. 2023; 8(1):239.

PMID: 37291105 PMC: 10248351. DOI: 10.1038/s41392-023-01502-8.

Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus.

Frasca D, Diaz A, Romero M, Blomberg B Front Aging. 2022; 2:715981.

PMID: 35822013 PMC: 9261392. DOI: 10.3389/fragi.2021.715981.

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.

Versteegen P, Barkoff A, Pinto M, van de Kasteele J, Knuutila A, Bibi S Front Immunol. 2022; 13:864674.

PMID: 35677044 PMC: 9168128. DOI: 10.3389/fimmu.2022.864674.

References

Frasca D, Landin A, Lechner S, Ryan J, Schwartz R, Riley R . Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol. 2008; 180(8):5283-90. DOI: 10.4049/jimmunol.180.8.5283. View

Zhou X, McElhaney J . Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine. 2011; 29(11):2169-77. PMC: 3057414. DOI: 10.1016/j.vaccine.2010.12.029. View

Goodwin K, Viboud C, Simonsen L . Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2005; 24(8):1159-69. DOI: 10.1016/j.vaccine.2005.08.105. View

Wrammert J, Smith K, Miller J, Langley W, Kokko K, Larsen C . Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008; 453(7195):667-71. PMC: 2515609. DOI: 10.1038/nature06890. View

Vu T, Farish S, Jenkins M, Kelly H . A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002; 20(13-14):1831-6. DOI: 10.1016/s0264-410x(02)00041-5. View

Bernasconi N, Traggiai E, Lanzavecchia A . Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002; 298(5601):2199-202. DOI: 10.1126/science.1076071. View

Sasaki S, He X, Holmes T, Dekker C, Kemble G, Arvin A . Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One. 2008; 3(8):e2975. PMC: 2500171. DOI: 10.1371/journal.pone.0002975. View

Frasca D, Diaz A, Romero M, Landin A, Blomberg B . Age effects on B cells and humoral immunity in humans. Ageing Res Rev. 2010; 10(3):330-5. PMC: 3040253. DOI: 10.1016/j.arr.2010.08.004. View

Crotty S, Aubert R, Glidewell J, Ahmed R . Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods. 2004; 286(1-2):111-22. DOI: 10.1016/j.jim.2003.12.015. View

10.

Cox R, Brokstad K, Zuckerman M, Wood J, Haaheim L, Oxford J . An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine. 1994; 12(11):993-9. DOI: 10.1016/0264-410x(94)90334-4. View

11.

Ferrucci L, Guralnik J, Pahor M, Corti M, Havlik R . Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA. 1997; 277(9):728-34. View

12.

Monto A, Ansaldi F, Aspinall R, McElhaney J, Montano L, Nichol K . Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 2009; 27(37):5043-53. DOI: 10.1016/j.vaccine.2009.06.032. View

13.

de Bruijn I, Remarque E, Jol-van der Zijde C, van Tol M, Westendorp R, Knook D . Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis. 1998; 179(1):31-6. DOI: 10.1086/314540. View

14.

Frasca D, Diaz A, Romero M, Landin A, Phillips M, Lechner S . Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine. 2010; 28(51):8077-84. PMC: 3223387. DOI: 10.1016/j.vaccine.2010.10.023. View

15.

Simonsen L, Clarke M, Schonberger L, Arden N, Cox N, Fukuda K . Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998; 178(1):53-60. DOI: 10.1086/515616. View

16.

McElhaney J, Effros R . Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol. 2009; 21(4):418-24. PMC: 2725188. DOI: 10.1016/j.coi.2009.05.023. View

17.

Hancock K, Veguilla V, Lu X, Zhong W, Butler E, Sun H . Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361(20):1945-52. DOI: 10.1056/NEJMoa0906453. View

18.

Wrammert J, Koutsonanos D, Li G, Edupuganti S, Sui J, Morrissey M . Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med. 2011; 208(1):181-93. PMC: 3023136. DOI: 10.1084/jem.20101352. View

19.

Greenbaum J, Kotturi M, Kim Y, Oseroff C, Vaughan K, Salimi N . Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A. 2009; 106(48):20365-70. PMC: 2777968. DOI: 10.1073/pnas.0911580106. View

20.

Sasaki S, Sullivan M, Narvaez C, Holmes T, Furman D, Zheng N . Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011; 121(8):3109-19. PMC: 3148747. DOI: 10.1172/JCI57834. View